Get the Stockscreener App
19.28
10.38%
1.84
Caredx Inc stock is traded at $19.28, with a volume of 559.09K.
It is up +10.38% in the last 24 hours and up +28.33% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$17.44
Open:
$18.22
24h Volume:
559.09K
Relative Volume:
0.58
Market Cap:
$1.07B
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-7.1673
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
+9.62%
1M Performance:
+28.33%
6M Performance:
-25.73%
1Y Performance:
+40.41%
1-Day Range:
$18.12
$19.75
1-Week Range:
$16.22
$19.75
52-Week Range:
$13.18
$34.84
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
19.28 | 981.65M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
405.48 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
195.14 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
528.45 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.22 | 31.61B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
148.06 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Established in Securities Fraud Class Action - ACCESS Newswire
CareDx announces new $50 million stock buyback program - Investing.com
CareDx Announces New $50 Million Stock Repurchase - TipRanks
CareDx (CDNA) Announces New $50M Share Repurchase Program - GuruFocus
CareDx Launches New $50 Million Share Buyback Plan - marketscreener.com
CareDx authorizes new repurchase of up to $50M of shares - TipRanks
CareDx (CDNA) Completes $50M Stock Buyback and Plans Further Repurchase | CDNA Stock News - GuruFocus
CareDx Announces Repurchase of 5% of Outstanding Shares | CDNA Stock News - GuruFocus
CareDx Announces Repurchase of 5% of Outstanding Shares - The Joplin Globe
Caredx Insider Sold Shares Worth $523,413, According to a Recent SEC Filing - marketscreener.com
Tidal Investments LLC Trims Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - Defense World
Director’s Major Stock Sale Shakes Up CareDx! - TipRanks
CareDx Inc (CDNA) Stock Price Down 5.58% on May 29 - GuruFocus
Nuveen Asset Management LLC Boosts Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
Ameriprise Financial Inc. Buys 38,101 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - Business Wire
Deutsche Bank AG Sells 23,401 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - GlobeNewswire Inc.
CareDx, Inc (NASDAQ:CDNA) Shares Acquired by BNP Paribas Financial Markets - Defense World
Northern Trust Corp Buys 33,788 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Learn to Evaluate (CDNA) using the Charts - news.stocktradersdaily.com
CareDx (NASDAQ:CDNA) Trading 5.8% Higher – Here’s What Happened - Defense World
CareDx Inc (CDNA) Trading 8.51% Higher on May 16 - GuruFocus
CareDx Agrees to Pay Settlement to $CDNA Investors — Here’s How to Get Your Share - TradingView
Transplantation Market Growth, Trends & Forecast 2025 | Top key playersCareDx, Inc., Hologic, Inc, QIAGEN. - openPR.com
Major Stock Sale by CareDx Director Revealed! - TipRanks
CareDx to Participate in Upcoming Investor Conferences - Bluefield Daily Telegraph
Price T Rowe Associates Inc. MD Has $581,000 Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx Secures Speaking Slots at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan
CareDx, Inc (NASDAQ:CDNA) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Dimensional Fund Advisors LP Sells 7,853 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
HC Wainwright Analysts Lift Earnings Estimates for CareDx - Defense World
CareDX, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
CareDx Director Makes a Significant Stock Sale! - TipRanks
Insider Sell: Christine Cournoyer Sells 16,700 Shares of CareDx Inc (CDNA) - GuruFocus
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance
Envestnet Asset Management Inc. Sells 1,596 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx (CDNA) Maintains Overweight Rating and $40 Price Target | - GuruFocus
CareDx (CDNA) Maintains Overweight Rating and $40 Price Target | CDNA Stock News - GuruFocus
Analyst Expectations For CareDx's Future - Benzinga
CareDx (CDNA) Stock Rating and Price Target Update | CDNA Stock News - GuruFocus
CareDx outlines $365M-$375M 2025 revenue target while advancing transplant solutions - MSN
CareDx, Inc (NASDAQ:CDNA) Shares Purchased by Wells Fargo & Company MN - Defense World
CDNA 7/22/22 DEADLINE: Lieff Cabraser Urges CareDx Investors to Contact Us About Pending Securities Fraud Action - ACCESS Newswire
Insider Sell: Peter Maag Sells 13,281 Shares of CareDx Inc (CDNA) - GuruFocus
Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 28% Undervaluation? - simplywall.st
BTIG cuts CareDx stock price target to $30, maintains Buy rating - Investing.com Australia
CareDx, Inc (NASDAQ:CDNA) Q1 2025 Earnings Call Transcript - Insider Monkey
An Intrinsic Calculation For CareDx, Inc (NASDAQ:CDNA) Suggests It's 28% Undervalued - Yahoo Finance
CareDx First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
CareDx (CDNA) Stock Sees Target Price Cut by BTIG Amid Market Vo - GuruFocus
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HAGSTROM WILLIAM A | Director |
May 28 '25 |
Sale |
17.45 |
30,000 |
523,413 |
53,979 |
0.34%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):